Company Encyclopedia
View More
name
MeHow
301363.SZ
MeHow Innovative Ltd. designs, develops, manufactures, and sells precision medical device components and products in China and internationally. The company primarily provides home ventilators, precision molds and automation equipment, surgical instruments, etc. It also offers variable dose pen, auto injector, auto secure dose pen; microfluidic solutions and laboratory consumables, such as cuvette, PCR tube, 96-well plates, freezing tubes, culture dish and bottle, suction head, and vacutainer; cardiovascular products, including electrophysiology catheter solutions, ablation catheter, high density mapping catheter, and intracardiac echocardiography; surgical solutions, such as ultrasonic scalpels, staplers, ligating clips, sterile-grade/implant-grade injection components, micro precision equipment components, automated assembly, and others.
900.37 B
301363.SZMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking7/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.86%B
    • Profit Margin19.25%A
    • Gross Margin44.24%B
  • Growth ScoreB
    • Revenue YoY12.49%B
    • Net Profit YoY15.88%B
    • Total Assets YoY10.68%B
    • Net Assets YoY9.26%B
  • Cash ScoreB
    • Cash Flow Margin519.57%C
    • OCF YoY12.49%B
  • Operating ScoreC
    • Turnover0.41C
  • Debt ScoreA
    • Gearing Ratio11.43%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CITIC Construction Investment: The medical device sector's revenue growth turned positive in Q3 2025, while the year-on-year decline in profit narrowed significantly compared to the previous quarter

    CITIC Construction Investment released a research report indicating that the medical device sector achieved positive revenue growth in Q3 2025, but the decline in profits year-on-year has narrowed. In the short term, it is recommended to focus on structural investment opportunities arising from performance improvements, while in the long term, attention should be paid to innovation, overseas expansion, and merger and acquisition integration opportunities. The medical services sector experienced a slight decline in revenue, with some consumer medical service companies seeing a rebound in performance. Looking ahead, improvements in bidding data will drive the overall recovery of the industry

    Zhitong·
    SZ
    301363
    -3.79%
    Zhitong·
    SZ
    301363
    -3.79%

    MeHow: In the field of surgical robots, products have already been supplied to customers in small batches

    MeHow stated in a conference call on October 22 that in the field of humanoid robots, the company's home and consumer electronics division is actively laying out development paths. Combining the company's technological accumulation in PEEK materials and their modifications, small motor-related components, and sensor research and development, it has initiated relevant product technology layouts and engaged with customers. In the field of surgical robots, the company has already supplied small batches of products to some domestic and foreign customers

    Zhitong·
    SZ
    301363
    -3.79%
    Zhitong·
    SZ
    301363
    -3.79%

    Guangdong Hotata Technology Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025

    Guangdong Hotata Technology Group Co.,Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,059.16 million compared to CNY 1,068.91 million a year ago. Net income was CNY 143.22 million compared to CNY 190.43 million a year ago.Basic earnings per share from continuing operations was CNY 0.36 compared to CNY 0.47 a year ago. Diluted earnings per share from continuing operations was CNY 0.36 compared to CNY 0.47 a year ago.

    marketscreener·
    SH
    603848
    -3.68%
    marketscreener·
    SH
    603848
    -3.68%

    MeHow released its performance for the first three quarters, with a net profit attributable to the parent company of 208 million yuan, a decrease of 19.25%

    According to the Zhitong Finance APP, MeHow released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.194 billion yuan, a year-on-year increase of 3.28%. The net profit attributable to shareholders of the listed company was 208 million yuan, a year-on-year decrease of 19.25%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 203 million yuan, a year-on-year decrease of 17.85%. The basic earnings per share were 0.37 yuan

    Zhitong·
    SZ
    301363
    -3.79%
    Zhitong·
    SZ
    301363
    -3.79%

    MeHow: Plans to distribute a cash dividend of 0.80 yuan for every 10 shares

    MeHow announced that the company achieved a net profit attributable to shareholders of listed companies of 208 million yuan in the first three quarters of 2025. The company plans to distribute a cash dividend of 0.80 yuan for every 10 shares based on a total share capital of 568 million shares, totaling a cash dividend distribution of 45.4191 million yuan. There will be no bonus shares issued this time, and no capital reserve will be converted into share capital

    Zhitong·
    SZ
    301363
    -3.79%
    Zhitong·
    SZ
    301363
    -3.79%